Skip to main content

Advertisement

Table 3 Area under the curve (AUC) in median (IQR), units are mmol/l × 120min except ISR measured in pmol/kg

From: Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease

Variable Baseline n Placebo n p Liraglutide n p Difference n p
Glucose 804.3 (735.5; 911.3) 31 − 75.9 (− 143.5; − 29.0) 29 0.0003 − 105.6 (− 213.0; − 40.8) 28 < .0001 − 44.8 (− 122.3; 33.8) 27 0.09
Insulin 36,103 (25,435; 48,380) 30 − 8530 (− 14,630; 1915) 29 0.006 − 11,270 (− 19,382; − 1145) 27 0.002 − 2195 (− 7745; 4250) 27 0.45
ISR 999 (840; 1281) 30 − 205 (− 360; − 32) 29 0.001 − 102 (− 260; 105) 26 0.08 69 (− 25; 247) 25 0.11
NEFA 29.1 (22.6; 37.9) 31 − 2.8 (− 7.5; 2.9) 30 0.06 2.7 (− 5.5; 13.4) 27 0.26 6.5 (− 5.7; 16.9) 27 0.13